Metformin alleviates type 2 diabetes-related depressive-like behaviors via AKAP150 signaling in NAc D1 medium spiny neurons
Abstract
Type 2 diabetes mellitus (T2DM) exhibits high comorbidity with depression, and progressive synaptic maladaptation of D1- and D2-expressing medium spine neurons (D1/D2-MSNs) in the nucleus accumbens (NAc) is critical involved in this pathological process. The first-line hypoglycemic drug metformin has been suggested to alleviates depressive symptoms. A-kinase anchoring protein 150 (AKAP150) modulates postsynaptic AMPA receptor (AMPAR) phosphorylation and synaptic function. However, the cell-type-specific role of AKAP150 in T2DM-related depression and its relevance to metformin's antidepressant mechanism remain unclear. Here, we established T2DM mouse models with depressive-like behaviors using D1-Cre and D2-Cre transgenic mice, combined with RNA sequencing, immunofluorescence, and electrophysiology and viral genetic manipulation to dissect NAc AKAP150 signaling. We detected specific downregulation of AKAP150 exclusively in D1-MSNs (rather than D2-MSNs) of T2DM mice and its expression level negatively correlated with the severity depressive-like phenotypes. Cell-specific overexpression of wild-type AKAP150 in D1-MSNs restored AMPAR-mediated synaptic transmission, corrected aberrant dendritic spine remodeling, and rescued T2DM-related depressive-like behaviors. In contrast, overexpression of a PKA-binding-deficient AKAP150 mutant failed to reverse these effects. Notably, metformin treatment selectively restored AKAP150 expression in D1-MSNs, rescued synaptic deficits and…
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.